Endovascular aneurysm repair in treatment of abdominal aortic aneurysm: a single-center analysis

    Authors

    Keywords

    endovascular aneurysm repair, abdominal aortic aneurysm

    DOI

    https://doi.org/10.15836/ccar2018.452

    Full Text

    Objective: To evaluate the outcome after endovascular aortic repair (EVAR) of abdominal aortic aneurysms (AAA) in single center. Patients and Methods: A total of 34 patients diagnosed with AAA treated by EVAR in University Hospital Centre Zagreb from June 2015 to September 2018 were followed-up and analyzed. There were 31/34 (91%) male and 3/34 (9%) female patients, with a mean age of 73.7±7.4 (range 55-87 years) in this study group. The primary outcome of the study was EVAR technical success (successful implantation) and all-cause mortality. Secondary endpoints were complications, length of stay in the ICU, and patient survival. Descriptive statistics were used to analyze the data. Results: Mean diameter of treated AAAs was 62.1±12 mm (range 43-98 mm). Technical success rate were 94% (32/34) for implantation stent-graft system. In one patient we failed to perform implantation because of wide and angulated AAA neck, and one patient had external iliac artery rupture. In the follow-up period we recorded 2/32 (6%) deaths in the group of successfully implanted patients who were not related to AAA and EVAR procedure. Most common complication after successful EVAR procedure were endoleak type II in 11/32 (34%) patients, without the need for reintervention. Average length of stay in ICU was 1.08 day. In patients with EVAR mean survival was 19±11 months (range from 1 to 40 months) after procedure. Conclusions: EVAR treatment for AAA is technically feasible and safe, with acceptable complications risks and with very short length stay in ICU after procedure. In order to prevent complications, extreme caution is needed when selecting patients who are anatomically suitable for the EVAR procedure. ( 1 )

    Cardiologia Croatica
    Back to search

    Endovascular aneurysm repair in treatment of abdominal aortic aneurysm: a single-center analysis

    Extended Abstract
    Issue11-12
    Published
    Pages452
    PDF via DOIhttps://doi.org/10.15836/ccar2018.452
    endovascular aneurysm repair
    abdominal aortic aneurysm

    Authors

    Dražen Perkov*ORCIDUniversity Hospital Centre Zagreb, Zagreb, Croatia
    Mladen PetrunićUniversity Hospital Centre Zagreb, Zagreb, Croatia
    Damir HalužanORCIDUniversity Hospital Centre Zagreb, Zagreb, Croatia
    Ivica SjekavicaUniversity Hospital Centre Zagreb, Zagreb, Croatia
    Majda Vrkić-KirhmajerORCIDUniversity Hospital Centre Zagreb, Zagreb, Croatia
    Ljiljana BanfićORCIDUniversity Hospital Centre Zagreb, Zagreb, Croatia

    Full Text

    Objective: To evaluate the outcome after endovascular aortic repair (EVAR) of abdominal aortic aneurysms (AAA) in single center. Patients and Methods: A total of 34 patients diagnosed with AAA treated by EVAR in University Hospital Centre Zagreb from June 2015 to September 2018 were followed-up and analyzed. There were 31/34 (91%) male and 3/34 (9%) female patients, with a mean age of 73.7±7.4 (range 55-87 years) in this study group. The primary outcome of the study was EVAR technical success (successful implantation) and all-cause mortality. Secondary endpoints were complications, length of stay in the ICU, and patient survival. Descriptive statistics were used to analyze the data. Results: Mean diameter of treated AAAs was 62.1±12 mm (range 43-98 mm). Technical success rate were 94% (32/34) for implantation stent-graft system. In one patient we failed to perform implantation because of wide and angulated AAA neck, and one patient had external iliac artery rupture. In the follow-up period we recorded 2/32 (6%) deaths in the group of successfully implanted patients who were not related to AAA and EVAR procedure. Most common complication after successful EVAR procedure were endoleak type II in 11/32 (34%) patients, without the need for reintervention. Average length of stay in ICU was 1.08 day. In patients with EVAR mean survival was 19±11 months (range from 1 to 40 months) after procedure. Conclusions: EVAR treatment for AAA is technically feasible and safe, with acceptable complications risks and with very short length stay in ICU after procedure. In order to prevent complications, extreme caution is needed when selecting patients who are anatomically suitable for the EVAR procedure. ( 1 )